[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Herpes Labialis Drugs Market Size, Status and Forecast 2022

October 2017 | 104 pages | ID: GAB179F1B2CWEN
QYResearch

US$ 3,300.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies the global Herpes Labialis Drugs market, analyzes and researches the Herpes Labialis Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like
  • GSK
  • Novartis
  • Teva
  • Mylan
  • Cadila
  • Apotex
  • Daewoong Pharmaceutical
  • Livzon
  • Luoxin
  • Med shine
  • Bayer (Campho Phenique)
  • Blistex
  • Kelun Group
  • Hikma
  • Haiwang
  • Carmex
  • Cipher
Market segment by Regions/Countries, this report covers
  • United States
  • EU
  • Japan
  • China
  • India
  • Southeast Asia
Market segment by Type, Herpes Labialis Drugs can be split into
  • Valacyclovir
  • Aciclovir
  • Famciclovir
  • Docosanol
  • Other
Market segment by Application, Herpes Labialis Drugs can be split into
  • External Use
  • Oral
  • Injection
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Herpes Labialis Drugs Market Size, Status and Forecast 2022

1 INDUSTRY OVERVIEW OF HERPES LABIALIS DRUGS

1.1 Herpes Labialis Drugs Market Overview
  1.1.1 Herpes Labialis Drugs Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Herpes Labialis Drugs Market Size and Analysis by Regions
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Herpes Labialis Drugs Market by Type
  1.3.1 Valacyclovir
  1.3.2 Aciclovir
  1.3.3 Famciclovir
  1.3.4 Docosanol
  1.3.5 Other
1.4 Herpes Labialis Drugs Market by End Users/Application
  1.4.1 External Use
  1.4.2 Oral
  1.4.3 Injection

2 GLOBAL HERPES LABIALIS DRUGS COMPETITION ANALYSIS BY PLAYERS

2.1 Herpes Labialis Drugs Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 GSK
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Herpes Labialis Drugs Revenue (Value) (2012-2017)
  3.1.5 Recent Developments
3.2 Novartis
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Herpes Labialis Drugs Revenue (Value) (2012-2017)
  3.2.5 Recent Developments
3.3 Teva
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Herpes Labialis Drugs Revenue (Value) (2012-2017)
  3.3.5 Recent Developments
3.4 Mylan
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Herpes Labialis Drugs Revenue (Value) (2012-2017)
  3.4.5 Recent Developments
3.5 Cadila
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Herpes Labialis Drugs Revenue (Value) (2012-2017)
  3.5.5 Recent Developments
3.6 Apotex
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Herpes Labialis Drugs Revenue (Value) (2012-2017)
  3.6.5 Recent Developments
3.7 Daewoong Pharmaceutical
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Herpes Labialis Drugs Revenue (Value) (2012-2017)
  3.7.5 Recent Developments
3.8 Livzon
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Herpes Labialis Drugs Revenue (Value) (2012-2017)
  3.8.5 Recent Developments
3.9 Luoxin
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Herpes Labialis Drugs Revenue (Value) (2012-2017)
  3.9.5 Recent Developments
3.10 Med shine
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Herpes Labialis Drugs Revenue (Value) (2012-2017)
  3.10.5 Recent Developments
3.11 Bayer (Campho Phenique)
3.12 Blistex
3.13 Kelun Group
3.14 Hikma
3.15 Haiwang
3.16 Carmex
3.17 Cipher

4 GLOBAL HERPES LABIALIS DRUGS MARKET SIZE BY TYPE AND APPLICATION (2012-2017)

4.1 Global Herpes Labialis Drugs Market Size by Type (2012-2017)
4.2 Global Herpes Labialis Drugs Market Size by Application (2012-2017)
4.3 Potential Application of Herpes Labialis Drugs in Future
4.4 Top Consumer/End Users of Herpes Labialis Drugs

5 UNITED STATES HERPES LABIALIS DRUGS DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Herpes Labialis Drugs Market Size (2012-2017)
5.2 United States Herpes Labialis Drugs Market Size and Market Share by Players (2016 and 2017)

6 EU HERPES LABIALIS DRUGS DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Herpes Labialis Drugs Market Size (2012-2017)
6.2 EU Herpes Labialis Drugs Market Size and Market Share by Players (2016 and 2017)

7 JAPAN HERPES LABIALIS DRUGS DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Herpes Labialis Drugs Market Size (2012-2017)
7.2 Japan Herpes Labialis Drugs Market Size and Market Share by Players (2016 and 2017)

8 CHINA HERPES LABIALIS DRUGS DEVELOPMENT STATUS AND OUTLOOK

8.1 China Herpes Labialis Drugs Market Size (2012-2017)
8.2 China Herpes Labialis Drugs Market Size and Market Share by Players (2016 and 2017)

9 INDIA HERPES LABIALIS DRUGS DEVELOPMENT STATUS AND OUTLOOK

9.1 India Herpes Labialis Drugs Market Size (2012-2017)
9.2 India Herpes Labialis Drugs Market Size and Market Share by Players (2016 and 2017)

10 SOUTHEAST ASIA HERPES LABIALIS DRUGS DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Herpes Labialis Drugs Market Size (2012-2017)
10.2 Southeast Asia Herpes Labialis Drugs Market Size and Market Share by Players (2016 and 2017)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)

11.1 Global Herpes Labialis Drugs Market Size (Value) by Regions (2017-2022)
  11.1.1 United States Herpes Labialis Drugs Revenue and Growth Rate (2017-2022)
  11.1.2 EU Herpes Labialis Drugs Revenue and Growth Rate (2017-2022)
  11.1.3 Japan Herpes Labialis Drugs Revenue and Growth Rate (2017-2022)
  11.1.4 China Herpes Labialis Drugs Revenue and Growth Rate (2017-2022)
  11.1.5 India Herpes Labialis Drugs Revenue and Growth Rate (2017-2022)
  11.1.6 Southeast Asia Herpes Labialis Drugs Revenue and Growth Rate (2017-2022)
11.2 Global Herpes Labialis Drugs Market Size (Value) by Type (2017-2022)
11.3 Global Herpes Labialis Drugs Market Size by Application (2017-2022)

12 HERPES LABIALIS DRUGS MARKET DYNAMICS

12.1 Herpes Labialis Drugs Market Opportunities
12.2 Herpes Labialis Drugs Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Herpes Labialis Drugs Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Herpes Labialis Drugs Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Herpes Labialis Drugs Product Scope
Figure Global Herpes Labialis Drugs Market Size (Million USD) (2012-2017)
Table Global Herpes Labialis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Herpes Labialis Drugs Market Share by Regions in 2016
Figure United States Herpes Labialis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Herpes Labialis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Herpes Labialis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Herpes Labialis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Herpes Labialis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Herpes Labialis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Herpes Labialis Drugs Market Share by Type in 2016
Figure Valacyclovir Market Size (Million USD) and Growth Rate (2012-2017)
Figure Aciclovir Market Size (Million USD) and Growth Rate (2012-2017)
Figure Famciclovir Market Size (Million USD) and Growth Rate (2012-2017)
Figure Docosanol Market Size (Million USD) and Growth Rate (2012-2017)
Figure Other Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Herpes Labialis Drugs Market Share by Application in 2016
Table Key Downstream Customer in External Use
Figure Herpes Labialis Drugs Market Size (Million USD) and Growth Rate in External Use (2012-2017)
Table Key Downstream Customer in Oral
Figure Herpes Labialis Drugs Market Size (Million USD) and Growth Rate in Oral (2012-2017)
Table Key Downstream Customer in Injection
Figure Herpes Labialis Drugs Market Size (Million USD) and Growth Rate in Injection (2012-2017)
Table Herpes Labialis Drugs Market Size (Million USD) by Players (2016 and 2017)
Figure Herpes Labialis Drugs Market Size Share by Players in 2016
Figure Herpes Labialis Drugs Market Size Share by Players in 2017
Table GSK Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of GSK (2012-2017)
Figure GSK Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Novartis Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Novartis (2012-2017)
Figure Novartis Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Teva Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Teva (2012-2017)
Figure Teva Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Mylan Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Mylan (2012-2017)
Figure Mylan Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Cadila Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Cadila (2012-2017)
Figure Cadila Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Apotex Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Apotex (2012-2017)
Figure Apotex Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Daewoong Pharmaceutical Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Daewoong Pharmaceutical (2012-2017)
Figure Daewoong Pharmaceutical Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Livzon Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Livzon (2012-2017)
Figure Livzon Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Luoxin Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Luoxin (2012-2017)
Figure Luoxin Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Med shine Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Med shine (2012-2017)
Figure Med shine Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Bayer (Campho Phenique) Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Bayer (Campho Phenique) (2012-2017)
Figure Bayer (Campho Phenique) Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Blistex Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Blistex (2012-2017)
Figure Blistex Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Kelun Group Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Kelun Group (2012-2017)
Figure Kelun Group Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Hikma Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Hikma (2012-2017)
Figure Hikma Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Haiwang Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Haiwang (2012-2017)
Figure Haiwang Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Carmex Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Carmex (2012-2017)
Figure Carmex Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Cipher Basic Information List
Table Herpes Labialis Drugs Business Revenue (Million USD) of Cipher (2012-2017)
Figure Cipher Herpes Labialis Drugs Business Revenue Market Share in 2016
Table Global Herpes Labialis Drugs Market Size (Million USD) by Type (2012-2017)
Figure Global Herpes Labialis Drugs Market Size Share by Type in 2012
Figure Global Herpes Labialis Drugs Market Size Share by Type in 2013
Figure Global Herpes Labialis Drugs Market Size Share by Type in 2014
Figure Global Herpes Labialis Drugs Market Size Share by Type in 2015
Figure Global Herpes Labialis Drugs Market Size Share by Type in 2016
Figure Global Herpes Labialis Drugs Market Size Share by Type in 2017
Table Global Herpes Labialis Drugs Market Size (Million USD) by Application (2012-2017)
Figure Global Herpes Labialis Drugs Market Size (Million USD) by Application in 2012
Figure Global Herpes Labialis Drugs Market Size (Million USD) by Application in 2013
Figure Global Herpes Labialis Drugs Market Size (Million USD) by Application in 2014
Figure Global Herpes Labialis Drugs Market Size (Million USD) by Application in 2015
Figure Global Herpes Labialis Drugs Market Size (Million USD) by Application in 2016
Figure Global Herpes Labialis Drugs Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Herpes Labialis Drugs
Figure United States Herpes Labialis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Herpes Labialis Drugs Market Size (Million USD) by Players (2012-2017)
Figure United States Herpes Labialis Drugs Market Size Share by Players in 2016
Figure United States Herpes Labialis Drugs Market Size Share by Players in 2017
Figure EU Herpes Labialis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Herpes Labialis Drugs Market Size (Million USD) by Players (2012-2017)
Figure EU Herpes Labialis Drugs Market Size Share by Players in 2016
Figure EU Herpes Labialis Drugs Market Size Share by Players in 2017
Figure Japan Herpes Labialis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Herpes Labialis Drugs Market Size (Million USD) by Players (2012-2017)
Figure Japan Herpes Labialis Drugs Market Size Share by Players in 2016
Figure Japan Herpes Labialis Drugs Market Size Share by Players in 2017
Figure China Herpes Labialis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Herpes Labialis Drugs Market Size (Million USD) by Players (2012-2017)
Figure China Herpes Labialis Drugs Market Size Share by Players in 2016
Figure China Herpes Labialis Drugs Market Size Share by Players in 2017
Figure India Herpes Labialis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Herpes Labialis Drugs Market Size (Million USD) by Players (2012-2017)
Figure India Herpes Labialis Drugs Market Size Share by Players in 2016
Figure India Herpes Labialis Drugs Market Size Share by Players in 2017
Figure Southeast Asia Herpes Labialis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Herpes Labialis Drugs Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Herpes Labialis Drugs Market Size Share by Players in 2016
Figure Southeast Asia Herpes Labialis Drugs Market Size Share by Players in 2017
Figure Global Herpes Labialis Drugs Market Size (Million USD) by Regions (2017-2022)
Table Global Herpes Labialis Drugs Market Size (Million USD) by Regions (2017-2022)
Figure Global Herpes Labialis Drugs Market Size Share by Regions in 2017
Figure Global Herpes Labialis Drugs Market Size Share by Regions in 2022
Figure United States Herpes Labialis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Herpes Labialis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Herpes Labialis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Herpes Labialis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Herpes Labialis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Herpes Labialis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Herpes Labialis Drugs Market Size (Million USD) by Type (2017-2022)
Figure Global Herpes Labialis Drugs Market Size Share by Type in 2017
Figure Global Herpes Labialis Drugs Market Size Share by Type in 2022
Table Global Herpes Labialis Drugs Market Size (Million USD) by Application (2017-2022)
Figure Global Herpes Labialis Drugs Market Size (Million USD) by Application in 2017
Figure Global Herpes Labialis Drugs Market Size (Million USD) by Application in 2022


More Publications